Aberrant function and differentiation of monocytes in end stage renal disease

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 6, 2012, Pages 453-459

  Laudański, Krzysztof ^a   Nowak, Zbigniew ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Dendritic cells; End stage renal disease; Inflammation; Monocyte

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE ACTIVATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEOPTERIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PHAGOCYTOSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOREGULATION; KIDNEY FAILURE; MONOCYTE; PROTEIN EXPRESSION; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; MONOCYTES; PHENOTYPE; RENAL DIALYSIS;

EID: 84872106052     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0191-0     Document Type: Review

References (73)

1. Abbott KC, Agodoa LY (2001) Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 56:124-131
2. Abbott KC, Agodoa LY (2002) Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 91:203-209
3. Abbott KC, Hypolite I, Tveit DJ et al (2001) Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron 89:426-432
4. Allavena P, Piemonti L, Longoni D et al (1998) IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28:359-369
5. Alscher DM, Pauli-Magnus C, Kirchgessner J (2000) A new lactatebased, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function. Nephron 86:62-69
6. Alscher DM, Bruckner A, Fritz P et al (2002) Metallothionein and dendritic cells in skin of end-stage renal disease patients not on dialysis, or on hemodialysis or peritoneal dialysis. Perit Dial Int 22:449-453
7. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27:669-692
8. Berg KE, Ljungcrantz I, Andersson L et al (2012) Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet 5:122-131
9. Betjes MG, Tuk CW, Struijk DG et al (1993a) Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis. Clin Exp Immunol 94:377-384
10. Betjes MG, Tuk CW, Struijk DG et al (1993b) Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 43:641-648
11. Bossola M, Luciani G, Giungi S et al (2010) Anorexia, fatigue and plasma interleukin-6 levels in chronic hemodialysis patients. Ren Fail 32:1049-1054
12. Brauner A, Hylander B, Lu Y (1998) Granulocyte stimulating factor in patients on peritoneal dialysis and LPS stimulated peripheral blood mononuclear cells. Inflammation 22:393-401
13. Calvano JE, Agnese DM, Um JY et al (2003) Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndromepositive patients with and without infection: relationship to tolerance. Shock 20:415-419
14. Cavaillon JM, Poignet JL, Fitting C et al (1992) Serum interleukin-6 in long-term hemodialyzed patients. Nephron 60:307-313
15. Chatenoud L, Jungers P, Descamps-Latscha B (1994) Immunological considerations of the uremic and dialyzed patient. Kidney Int Suppl 44:S92-S96
16. Choi HM, Woo YS, Kim MG et al (2011) Altered monocyte-derived dendritic cell function in patients on hemodialysis: a culprit for underlying impaired immune responses. Clin Exp Nephrol 15:546-553
17. De A, Laudanski K, Miller-Graziano CL (2003) Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J Immunol 170:6355-6362
18. Descamps-Latscha B, Herbelin A, Nguyen AT et al (1994) Immune system dysregulation in uremia. Semin Nephrol 14:253-260
19. Descamps-Latscha B, Herbelin A, Nguyen AT et al (1995) Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892
20. Gawaz MP, Mujais SK, Schmidt B et al (1994) Platelet-leukocyte aggregation during hemodialysis. Kidney Int 46:489-495
21. Geissmann F, Auffray C, Palframan R et al (2008) Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 86:398-408
22. Girndt M, Sester U, Kaul H et al (1998) Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol 9:1689-1696
23. Girndt M, Sester M, Sester U et al (2001a) Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 59:1382-1389
24. Girndt M, Sester M, Sester U et al (2001b) Molecular aspects of Tand B-cell function in uremia. Kidney Int Suppl 78:S206-S211
25. Girndt M, Sester U, Sester M et al (2001c) The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 60:2385-2391
26. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964
27. Hubel E, Kiefer T, Weber J et al (1991) In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int 40:927-933
28. Jeneway C (2004) Immunobiology. Garland Science, New York
29. Joffre O, Nolte MA, Sporri R et al (2009) Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 227:234-247
30. Kamalakannan D, Pai RM, Johnson LB et al (2007) Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg 83:2081-2086
31. Kawanaka N, Nagake Y, Yamamura M et al (2002) Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure. Nephron 90:64-71
32. Kimmel PL, Phillips TM, Simmens SJ et al (1998) Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244
33. Kimmel M, Alschner DM, Dunst R et al (2006) The role of microinflammation in the pathogenesis of uraemic pruritis in haemodialysis patients. Nephrol Dial Transplant 21:749-755
34. Kurz P, Kohler H, Meuer S et al (1986) Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 29:1209-1214
35. Le Meur Y, Lorgeot V, Aldigier JC et al (1999) Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients. Nephrol Dial Transplant 14:2420-2426
36. Lewis SL, Van Epps DE (1987) Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 9:381-395
37. Libetta C, Rampino T, Dal Canton A (2001) Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 38:286-295
38. Lim WH, Kireta S, Russ GR et al (2007) Uremia impairs blood dendritic cell function in hemodialysis patients. Kidney Int 71:1122-1131
39. Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93-99
40. Malaponte G, Bevelacqua V, Fatuzzo P et al (2002) IL-1beta, TNFalpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age. Nephrol Dial Transplant 17:1964-1970
41. Marchant A, Tielemans C, Husson C et al (1996) Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation. Nephrol Dial Transplant 11:657-662
42. Memoli B, Postiglione L, Cianciaruso B et al (2000) Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int 58:417-424
43. Mettang T, Fritz P, Weber J et al (1993) Epidermal langerhans cells in uremic patients on hemodialysis or continuous ambulatory peritoneal dialysis. Nephron 65:278-283
44. Mettang T, Pauli-Magnus C, Alsher DM (2002) Uraemic pruritus- new perspectives and insights from recent trials. Nephrol Dial Transplant 17:1558-1563
45. Meuwese CL, Sneadal S, Halbesma N et al (2011) Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-alpha are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant 26:1313-1318
46. Morita Y, Yamamura M, Kashihara N et al (1997) Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients. Res Commun Mol Pathol Pharmacol 98:19-33
47. Nockher WA, Scherberich JE (1998) Expanded CD14+CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 66:2782-2790
48. O'Byrne D, Devaraj S, Islam KN et al (2001) Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. Metabolism 50:207-215
49. Ooi YM, Ooi BS (1983) Identification of a monocyte phagocytic defect in a subpopulation of patients with nephritis. Kidney Int 23:851-854
50. Ozdemir FN, Guz G, Kayatas M et al (1998) Tuberculosis remains an important factor in the morbidity and mortality of hemodialysis patients. Transplant Proc 30:846-847
51. Ozdemir FN, Guz G, Sezer S et al (2001) Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients. Artif Organs 25:448-452
52. Paczek L, Schaefer RM, Heidland A (1991) Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol Dial Transplant 6(Suppl 3):41-44
53. Palucka AK, Banchereau J (2006) Langerhans cells: daughters of monocytes. Nat Immunol 7:223-224
54. Papagianni A, Kalovoulos M, Kirmizis D et al (2003) Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 18:113-119
55. Papayianni A, Alexopoulos E, Giamalis P et al (2002) Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant 17:435-441
56. Pastores GM (1997) Gaucher's disease. Pathological features. Baillieres Clin Haematol 10:739-749
57. Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z et al (2008) Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients. Can J Physiol Pharmacol 86:205-209
58. Pesanti EL (2001) Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 15:813-832
59. Puig-Kroger A, Pello OM, Selgas R et al (2007) Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucosedegradation products. J Leukoc Biol 73:482-492
60. Rus HG, Cristea A, Gherman M et al (1983) Immunologic alterations associated with chronic hemodialysis. Med Interne 21:289-295
61. Saionji K, Ohsaka A (2001) Expansion of CD4+CD16+ blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor. Acta Haematol 105:21-26
62. Schauer S, Stein G, Suss J et al (1991) Phagocytosis activity of polymorphonuclear cells of normal persons and dialysis patients is influenced by different dialysis membranes. Nephrol Dial Transplant 6(Suppl 3):35-40
63. Sezer S, Ozdemir FN, Turan M et al (1998) Comparison of panel reactive antibody levels with clinical and laboratory parameters in end-stage renal disease patients. Transplant Proc 30:844-845
64. Sezer S, Ozdemir FN, Guz G et al (2000) Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc 32:607-608
65. Stefater JA 3rd, Ren S, Lang RA et al (2011) Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends Mol Med 17:743-752
66. Stewart-Phillips JL, Gagnon RF, Stranix B (1990) Macrophage secretory activity and atherosclerosis during chronic renal failure. Adv Perit Dial 6:224-229
67. Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609-618
68. Takahashi T, Kubota M, Nakamura T et al (2000) Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail 22:345-354
69. Vamvakas S, Bahner U, Heidland A (1998) Cancer in end-stage renal disease: potential factors involved -editorial. Am J Nephrol 18:89-95
70. Ventura MT, Di Corato R, Giuliano G et al (1998) Evaluation of monocyte chemotactic responsiveness in uraemic patients undergoing haemodialysis with different dialytic membranes. Cytobios 96:171-178
71. Weber C, Stummvoll HK, Passon S et al (1998) Monocyte activation and humoral immune response to endotoxins in patients receiving on-line hemodiafiltration therapy. Int J Artif Organs 21:335-340
72. Wu L, Vandenabeele S, Georgopoulos K (2001) Derivation of dendritic cells from myeloid and lymphoid precursors. Int Rev Immunol 20:117-135
73. Ziegler-Heitbrock HW (2000) Definition of human blood monocytes. J Leukoc Biol 67:603-606